Because Accenture's average analyst price target currently sits below the stock's market price, a standard consensus-derived objective would be meaningless. The $300 figure instead comes from public discussion: it is the highest price target in the current analyst range reported by S&P Global and a round-number psychological level just above the stock's 52-week high of $291.09. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For context, 27 analysts polled by S&P Global put the average ACN price target near $229.74, with individual estimates spanning roughly $163 to $300. Recent revisions illustrate the divergence. Wells Fargo raised its target to $252 from $210, while Stifel and Evercore ISI hold targets of $242 and $250, respectively, and TD Cowen sits at a more cautious $201. The wide spread reflects genuine disagreement about how AI will reshape Accenture's business and how quickly demand recovers.
Accenture shares closed at $249.37 on October 23, 2026, giving the company a market capitalization of roughly $152.6 billion. Reaching $300 would require a gain of about 20.3% — a substantial move, not a trivial one. The stock has already staged a dramatic rebound, roughly doubling from its 52-week low near $118, and it now trades above its 50-day and 200-day moving averages.
On valuation, the stock trades at roughly 18.4 times trailing EPS (earnings per share) of $13.56 and about 16 times forward earnings, with trailing revenue near $74.2 billion. The path toward $300 would require investors to pay a higher multiple than the average analyst currently assigns, or for earnings estimates to keep rising as AI and cloud work translates into revenue and margin improvement.
Accenture's core franchise remains strong. It has deep, long-standing relationships with the world's largest enterprises, a diversified client base, and a leading position in AI, cloud, and digital transformation consulting. If enterprise technology budgets recover and companies accelerate AI adoption, Accenture's bookings, revenue growth, and free cash flow could all expand, supporting earnings revisions higher.
The company also returns significant capital to shareholders, with a dividend yield near 2.7% and a history of buybacks, which can cushion downside. A favorable macro backdrop — lower interest rates and improving corporate confidence — would reinforce enterprise spending and could draw buyers toward the stock.
The clearest obstacle is that Accenture already trades above its average analyst price target. If analysts are correct, the stock may have gotten ahead of its fundamentals after the sharp October rally. AI also poses a genuine strategic risk: if generative AI reduces demand for traditional labor-intensive consulting and outsourcing, Accenture's growth and margins could face sustained pressure.
Other risks include a slowdown in global IT spending, foreign-exchange headwinds from its international revenue base, intensifying competition, and the possibility that the recent price surge simply stalls near the $291 52-week high.
The most important overhead level is the 52-week high of $291.09, which sits just below the $300 round-number target. A move to $300 would require first clearing that prior peak. On the downside, the $240 area and the $228–$230 zone — where the stock consolidated in late October — offer near-term support, with deeper support around $213 and $200. With the stock well above its 50-day and 200-day moving averages, the near-term trend is strong but extended, leaving room for consolidation.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms vary. The next key catalyst is Accenture's earnings report, scheduled for December 17, 2026, with current-quarter EPS estimates near $3.90. Investors should watch guidance, new bookings, AI-related revenue disclosures, and any analyst target revisions, as well as broader enterprise-IT-spending data and interest-rate signals that influence corporate budgets. From what I see, the December report will be especially telling.
I find Tickeron’s AI Daily Buy/Sell Signals helpful for tracking names like ACN because the tool applies artificial intelligence to monitor thousands of stocks and ETFs in real time. It generates Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis, which can complement traditional research when following a stock with wide analyst disagreement.
The question of whether Accenture can reach $300 is less about a single catalyst and more about whether the market will assign the stock a richer valuation than the average analyst currently does. The $300 objective — drawn from the highest current analyst target and the nearby 52-week high — implies a substantial 20% advance from $249.37. Support comes from strong AI and cloud demand, a powerful recovery from the 52-week low, and healthy free cash flow. The main obstacles are a share price already above the average analyst target and the disruptive threat of generative AI to traditional IT services. With a wide $163-to-$300 analyst range, disagreement is real, and the December earnings report and guidance will be critical in shaping the next leg. No outcome is guaranteed, and investors should weigh the risks as carefully as the upside. I’m watching this closely as earnings approach.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
ACN saw its Momentum Indicator move below the 0 level on November 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 78 similar instances where the indicator turned negative. In 49 of the 78 cases, the stock moved further down in the following days. The odds of a decline are at 63%.
The Moving Average Convergence Divergence Histogram (MACD) for ACN turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 27 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 55%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ACN's RSI Oscillator exited the oversold zone, 22 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
ACN moved above its 50-day moving average on November 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for ACN moved above the 200-day moving average on October 19, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +4.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACN advanced for three days, in 184 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
ACN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 135 of 197 cases where ACN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.
The Tickeron SMR rating for this company is 38 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. ACN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.999) is normal, around the industry mean (2.936). P/E Ratio (20.625) is within average values for comparable stocks, (18.739). Projected Growth (PEG Ratio) (1.268) is also within normal values, averaging (2.331). Dividend Yield (0.026) settles around the average of (0.228) among similar stocks. P/S Ratio (1.618) is also within normal values, averaging (141.748).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an investment holding company with interest in providing management consulting, technology and outsourcing services
Industry InformationTechnologyServices